[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337102-105":59,"doc-detail-337102-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","proteogenomic-analysis-dissects-early-onset-breast-cancer-patients-with-prognostic-relevance","Proteogenomic analysis dissects early-onset breast cancer patients with prognostic relevance","","Early-onset breast cancer shows aggressive clinical behavior and higher prevalence in East Asian populations, yet its molecular basis remains insufficiently defined. This proteogenomic study analyzed 126 treatment-naïve primary tumors from Korean patients aged ≤40 by integrating genomic, transcriptomic, and proteomic data. Five functional molecular subgroups were identified, enabling HER2 proteogenomic stratification and prognostic refinement. A proteome-based homologous recombination deficiency approach supports discovery of new groups for targeted HR deficiency therapy, while protein–RNA correlations forecast late recurrence in hormone receptor-positive disease.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/proteogenomic-analysis-dissects-early-onset-breast-cancer-patients-with-prognostic-relevance/337102/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/proteogenomic-analysis-dissects-early-onset-breast-cancer-patients-with-prognostic-relevance/337102.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How many early-onset breast cancer samples were analyzed and what were the key data types integrated?","Question",{"text":112,"@type":113},"The study analyzed 126 treatment-naïve primary tumor tissues from Korean patients aged ≤40. It integrated genomic, transcriptomic, and proteomic data to derive molecular insights.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What did the proteogenomic analysis reveal about molecular subgroups in young breast cancer?",{"text":117,"@type":113},"Five distinct functional subgroups were identified that represent clinical characteristics and biological behaviors. These subgroups support improved prognostic interpretation for patients with young breast cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the study estimate homologous recombination deficiency (HRD) and what is its potential value?",{"text":121,"@type":113},"The paper presents a proteome-based homologous recombination deficiency (HRD) analysis intended to address limitations of conventional genomic HRD tests. It may help identify additional patient groups needing targeted HR deficiency treatments.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337102,1790193033,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","[www.nature.com/emm](www.nature.com/emm)  \nARTICLE OPEN  \nProteogenomic analysis dissects early-onset breast cancer patients with prognostic relevance  \nKyong-Ah Yoon 1,12, Youngwook Kim2,12, So-Youn Jung2,3,12, Jin-Sun Ryu 4,5, Kyung-Hee Kim2,6, Eun-Gyeong Lee3, Heejung Chae7,8, Youngmee Kwon3, Jaegil Kim9, Jong Bae Park 2,13 ✉ and Sun-Young Kong 2,10,11,13 ✉  \n© The Author(s) 2024  \n\n| | Early-onset breast cancer is known for its aggressive clinical characteristics and high prevalence in East Asian countries, but a comprehensive understanding of its molecular features is still lacking. In this study, we conducted a proteogenomic analysis of 126 treatment-naïve primary tumor tissues obtained from Korean patients with young breast cancer (YBC) aged ≤40 years. By integrating genomic, transcriptomic, and proteomic data, we identiﬁed ﬁve distinct functional subgroups that accurately represented the clinical characteristics and biological behaviors of patients with YBC. Our integrated approach could be used to determine the proteogenomic status of HER2, enhancing its clinical signiﬁcance and prognostic value. Furthermore, we present aproteome-based homologous recombination deﬁciency (HRD) analysis that has the potential to overcome the limitations of conventional genomic HRD tests, facilitating the identiﬁcation of new patient groups requiring targeted HR deﬁciency treatments. Additionally, we demonstrated that protein–RNA correlations can be used to predict the late recurrence of hormone receptorpositive breast cancer. Within each molecular subtype of breast cancer, we identiﬁed functionally signiﬁcant protein groups whose differential abundance was closely correlated with the clinical progression of breast cancer. Furthermore, we derived a recurrence predictive index capable of predicting late recurrence, speciﬁcally in luminal subtypes, which plays a crucial role in guiding decisions on treatment durations for YBC patients. These ﬁndings improve the stratiﬁcation and clinical implications for patients | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | with YBC by contributing to the optimal adjuvant treatment and duration for favorable clinical outcomes. |  |\n|  |  |  |\n|  |  |  |\n|  | Experimental & Molecular Medicine (2024) 56:2382–2394; [https://doi.org/10.1038/s12276-024-01332-w](https://doi.org/10.1038/s12276-024-01332-w) |  |\n|  |  |  |\n\nINTRODUCTION  \nBreast cancer is the most common malignancy among women globally1 and is the leading cancer among women in Korea2. The occurrence of young breast cancer (YBC), i.e., breast cancer inpatients aged 40 years or younger at diagnosis, is rare; however, its proportional incidence in Korea is approximately 10%3, which is twice the incidence rate in the US4. Patients with YBC have a genetic susceptibility caused by BRCA1/2 pathogenic variants, showing aggressive clinical phenotypes with advanced stages, high-grade and triple-negative breast cancer (TNBC), and an unfavorable prognosis, including late recurrence5–8. However, the molecular features of YBC underlying these more aggressive tumor characteristics and worse clinical outcomes are unclear. Several studies have revealed the characteristics of YBC. With respect to somatic mutations, the Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) databases revealed that premenopausal (PreM) patients with breast cancer have greater numbers of mutations in 5 genes—CDH1, GATA3, MLL3, GPS2, and PI3KCA.  \nMoreover, compared to post-menopausal (PostM) tumors, gene expression in PreM tumors is enriched in the integrin and laminin signaling pathways, EGFR signaling activation, and TGF-β, especially in estrogen receptor-positive (ER + ) breast cancer9. Another study revealed that, compared with Western patients, Asian PreM patients presented a characteristic increase in tumor","cbCaifzkOZj7rkuM","https://ap.wps.com/l/cbCaifzkOZj7rkuM","pdf",4795343,13,"English","# Introduction\n# Proteogenomic analysis of young breast cancer\n# Prognostic subgrouping and HER2 relevance\n# Proteome-based HRD and targeted therapy implications\n# Protein–RNA correlations and late recurrence prediction\n# Protein groups linked to clinical progression\n# Recurrence predictive index for luminal subtypes","[{\"question\":\"How many early-onset breast cancer samples were analyzed and what were the key data types integrated?\",\"answer\":\"The study analyzed 126 treatment-naïve primary tumor tissues from Korean patients aged ≤40. It integrated genomic, transcriptomic, and proteomic data to derive molecular insights.\"},{\"question\":\"What did the proteogenomic analysis reveal about molecular subgroups in young breast cancer?\",\"answer\":\"Five distinct functional subgroups were identified that represent clinical characteristics and biological behaviors. These subgroups support improved prognostic interpretation for patients with young breast cancer.\"},{\"question\":\"How does the study estimate homologous recombination deficiency (HRD) and what is its potential value?\",\"answer\":\"The paper presents a proteome-based homologous recombination deficiency (HRD) analysis intended to address limitations of conventional genomic HRD tests. It may help identify additional patient groups needing targeted HR deficiency treatments.\"}]","Proteogenomic analysis dissects early-onset breast cancer patients with prognostic relevance | PDF",1790017711,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d693663cec49425589ddab68d7de5f3.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10d2b3064dbf0b6f4cc2357046692484.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd9c063c94707f8e0ece83db12508244.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/62be6ecb53664dffb5074dedeb45914d.webp",980,1301]